Gastroenterology and Hepatology
Message from the Chief
W. Ray Kim, MD, Division Chief
Welcome to the Division of Gastroenterology & Hepatology, a progressive center of excellence dedicated to advances in laboratory and clinical science, state-of-the art clinical care, and the education of future leaders in digestive and liver diseases.The Division is renowned for its pioneers in fundamental research and we continue this tradition with our wide array of ongoing investigative studies, including translational research dedicated to improving the lives of patients with complex gastrointestinal and liver disease. see more.
The Division of Gastroenterology and Hepatology has a long tradition of major contributions in basic research, a new commitment to clinical and outcomes research, a track record of training fellows for academic careers, and a longitudinal commitment to providing care for patients with complex gastrointestinal and liver diseases.
The faculty care for patients at the following three sites
- Stanford University Medical Center
- Palo Alto Veterans Affairs Health Care System,
- Santa Clara Valley Medical Center
Survey: Reproductive counseling is often MIA in IBD
REPORTING FROM THE CROHN’S & COLITIS CONGRESS
LAS VEGAS – Inflammatory bowel disease (IBD) can disrupt both fertility and pregnancy, especially if it’s not fully controlled, and there’s a risk that the condition can be passed onto an unborn child. Still a new study suggests many patients with IBD don’t receive appropriate reproductive counseling. continue reading
Oscar Salvatierra founded Stanford’s pediatric kidney transplant program, helped write the national legislation that regulates organ transplants, and conducted research in kidney transplantation.
On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the thinking in his field about what causes a common and often lethal heart defect.
Edward Rubenstein was an internist, an educator and an investigator of varied research topics, including synchrotron medical imaging.
Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.
Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.